The Library
Biosensor measurement of purine release from cerebellar cultures and slices
Tools
Wall, Mark J., Eason, Robert and Dale, Nicholas. (2010) Biosensor measurement of purine release from cerebellar cultures and slices. Purinergic Signalling, Vol.6 (No.3). pp. 339-348. ISSN 1573-9546
|
PDF
WRAP_Wall_dale_biosensor_measurement_purine.pdf - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader Download (402Kb) |
Official URL: http://dx.doi.org/10.1007/s11302-010-9185-8
Abstract
We have previously described an action-potential and Ca2+-dependent form of adenosine release in the molecular layer of cerebellar slices. The most likely source of the adenosine is the parallel fibres, the axons of granule cells. Using microelectrode biosensors, we have therefore investigated whether cultured granule cells (from postnatal day 7–8 rats) can release adenosine. Although no purine release could be detected in response to focal electrical stimulation, purine (adenosine, inosine or hypoxanthine) release occurred in response to an increase in extracellular K+ concentration from 3 to 25 mM coupled with addition of 1 mM glutamate. The mechanism of purine release was transport from the cytoplasm via an ENT transporter. This process did not require action-potential firing but was Ca2+dependent. The major purine released was not adenosine, but was either inosine or hypoxanthine. In order for inosine/hypoxanthine release to occur, cultures had to contain both granule cells and glial cells; neither cellular component was sufficient alone. Using the same stimulus in cerebellar slices (postnatal day 7–25), it was possible to release purines. The release however was not blocked by ENT blockers and there was a shift in the Ca2+ dependence during development. This data from cultures and slices further illustrates the complexities of purine release, which is dependent on cellular composition and developmental stage.
| Item Type: | Journal Article |
|---|---|
| Subjects: | Q Science > QP Physiology |
| Divisions: | Faculty of Science > Life Sciences (2010- ) > Biological Sciences ( -2010) Faculty of Medicine > Warwick Medical School |
| Library of Congress Subject Headings (LCSH): | Adenosine, Cerebellum, Axons, Purines |
| Journal or Publication Title: | Purinergic Signalling |
| Publisher: | Springer Netherlands |
| ISSN: | 1573-9546 |
| Date: | September 2010 |
| Volume: | Vol.6 |
| Number: | No.3 |
| Page Range: | pp. 339-348 |
| Identification Number: | 10.1007/s11302-010-9185-8 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Open Access |
| Funder: | Medical Research Council (Great Britain) (MRC) |
| References: | 1. Boison D (2006) Adenosine kinase, epilepsy and stroke: mechanisms and therapies. Trends Pharmcol Sci 27:652–658 2. Jacobson KA, Gao Z (2006) Adenosine receptors as therapeutic targets. Nature Reviews 5:247–264 3. Dale N, Frenguelli B (2007) Release of adenosine and ATP during ischemia and epilepsy. Curr Neuropharmacol 7:160–179 4. Fredholm BB, Ijzerman AP, Jacobson KA, Klotz KN, Linden J (2001) International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53:527–252 5. Fredholm BB (2003) Adenosine receptors as targets for drug development. Drug News Perspect 16:283–289 6. Wall MJ, Dale N (2008) Activity-dependent release of adenosine: a critical re-evaluation of mechanism. Curr Neuropharmacol 6:329–337 7. Latini S, Pedata F (2001) Adenosine in the central nervous system: release mechanisms and extracellular concentrations. J Neurochem 79:463–484 8. Burnstock G (2007) Physiology and pathophysiology of purinergic neurotransmission. Physiol Rev 87:659–797 9. Jo YH, Schlichter R (1999) Synaptic co-release of ATP and GABA in cultured spinal neurons. Nat Neurosci 2:241–245 10. Pearson RA, Dale N, Llaudet E, Mobbs P (2005) ATP released via gap junction hemichannels from the pigment epithelium regulates neural retinal progenitor proliferation. Neuron 46:731–44 11. Sweeney MI (1996) Adenosine release and uptake in cerebellar granule neurons both occur via an equilibrative nucleoside carrier that is modulated by G proteins. J Neurochem 67:81–88 12. Craig CG, White TD (1993) N-methyl-D-aspartate and non-Nmethyl- D-aspartate-evoked adenosine release from rat cortical slices: distinct purinergic sources and mechanisms of release. J Neurochem 60:1073–1080 13. Wall MJ, Dale N (2007) Auto-inhibition of parallel fibre-Purkinje cell synapses by activity dependent adenosine release. J Physiol 581:553–566 14. Llaudet E, Botting N, Crayston J, Dale N (2003) A three enzyme microelectrode sensor for detecting purine release from central nervous system. Biosens Bioelectron 18:43–52 15. Llaudet E, Hatz S, Droniou M, Dale N (2005) Microelectrode biosensor for real-time measurement of ATP in biological tissue. Anal Chem 77:3267–3273 16. Tomasellia B, Zur Nedden S, Podhraski V, Baier-Bitterlich B (2008) MAPK is an essential effector for purine nucleosidemediated neuroprotection of hypoxic PC12 cells and primary cerebellar granule neurons. Mol Cell Neurosci 38:559–568 17. Frenguelli BG, Llaudet E, Dale N (2003) High-resolution realtime recording with microelectrode biosensors reveals novel aspects of adenosine release during hypoxia in rat hippocampal slices. J Neurochem 86:1506–15 18. Parkinson FE, Xiong W (2004) Stimulus- and cell-type-specific release of purines in cultured rat forebrain astrocytes and neurons. J Neurochem 88:1305–1312 19. Noji T, Karaswa A, Kusaka H (2004) Adenosine uptake inhibitors. Eur J Pharm 495:1–16 20. Wall MJ, Atterbury A, Dale N (2007) Control of basal extracellular adenosine concentration in rat cerebellum. J Physiol 582:137–152 21. Atterbury A, Wall MJ (2009) Adenosine signalling at immature parallel fibre-Purkinje cell synapses in rat cerebellum. J Physiol 587:4497–4509 22. Parkinson FE, Sinclair CJ, Othman T, Haughey NJ, Geiger JD (2002) Differences between rat primary cortical neurons and astrocytes in purine release evoked by ischemic conditions. Neuropharmacology 43:836–46 23. Schultz V, Lowenstein JM (1976) Purine nucleotide cycle: evidence for the occurrence of the cycle in brain. J Biol Chem 251:485–492 24. Norenberg MD, Rao KV, Jayakumar AR (2005) Mechanisms of ammonia-induced astrocyte swelling. Metab Brain Dis 20:303– 318 25. Sinclair CJ, LaRivière CG, Young JD, Cass CE, Baldwin SA, Parkinson FE (2000) Purine uptake and release in rat C6 glioma cells: nucleoside transport and purine metabolism under ATPdepleting conditions. J Neurochem 75:1528–38 26. Almaraz L, García-Sancho J (1989) Activation by calcium of AMP deaminase from the human red cell. FEBS Lett 244:417–20 27. Mahnke DK, Sabina RL (2005) Calcium activates erythrocyte AMP deaminase [isoform E (AMPD3)] through a protein-protein interaction between calmodulin and the N-terminal domain of the AMPD3 polypeptide. Biochemistry 44:5551–9 28. Guinzberg R, Cortés D, Díaz-Cruz A, Riveros-Rosas H, Villalobos-Molina R, Piña E (2006) Inosine released after hypoxia activates hepatic glucose liberation through A3 adenosine receptors. Am J Physiol Endocrinol Metab 290:940–51 29. Hasko G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacol Sci 25:152– 157 30. Zurn AD, Do KQ (1988) Purine metabolite inosine is an adrenergic neurotrophic substance for cultured chicken sympathetic neurons. Proc Natl Acad Sci U S A 85:8301–5 31. Braumann T, Jastorff B, Richter-Landsberg C (1986) Fate of cyclic nucleotides in PC12 cell cultures: uptake, metabolism, and effects of metabolites on nerve growth factor-induced neurite outgrowth. J Neurochem 47:912–9 32. Rathbone MP, Middlemiss PJ, Crocker CE, Glasky MS, Juurlink BH, Ramirez JJ, Ciccarelli R, Di Iorio P, Caciagli F (1999) AIT- 082 as a potential neuroprotective and regenerative agent in stroke and central nervous system injury. Expert Opin Investig Drugs 8:1255–62 33. Mink R, Johnston J (2007) The effect of infusing hypoxanthine or xanthine on hypoxic-ischemic brain injury in rabbits. Brain Res 1147:256–64 34. Ascherio A, LeWitt PA, Xu K, Eberly S, Watts A, Matson WR, Marras C, Kieburtz K, Rudolph A, Bogdanov MB, Schwid SR, Tennis M, Tanner CM, Beal MF, Lang AE, Oakes D, Fahn S, Shoulson I, Schwarzschild MA (2009) Urate as a predictor of the rate of clinical decline in Parkinson disease. Arch Neurol 66:1460–8 |
| URI: | http://wrap.warwick.ac.uk/id/eprint/35161 |
Data sourced from Thomson Reuters' Web of Knowledge
Actions (login required)
![]() |
View Item |
Tools
Tools

